drugset / Trial / NCT06812390
Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Phase 2
Recruiting
20 enrolled
Anahita Rabiee MD MHS
Grifols Shared Services North America, Inc. · collab
RandomizedCrossoverQuadruple-blindOther
Summary
A small, pilot proof-of-concept placebo-controlled trial to explore the effects of albumin on diuresis in patients with cirrhosis, ascites and lower extremity edema. We will additionally investigate albumin's effect on preventing neurohumoral activation, and acute kidney injury after diuresis.
Timeline
- Start
- 2025-02-28
- Primary completion
- 2026-12
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albumin | Protein / enzyme biologic | 25 g | — |